UNH research seeks to quantify health outcomes based on food access, fiber intake and gut microbiota

The U.S. obesity epidemic continues to have profound impacts on individuals’ health and socioeconomic well-being

Risk Adjusted Net Present Value: What is the current valuation of AstraZeneca’s Puxitatug Samrotecan

The revenue for Puxitatug Samrotecan is expected to reach an annual total of $31 mn by 2039 in the US based off GlobalData’s Expiry Model.

September 19, 2023

ArriVent prices $175M IPO in back-to-back oncology biotech listings

ArriVent Biopharma will join the Nasdaq on Friday morning in a strong start to biotech’s first batch of initial public offerings this year. The Pennsylvania

January 27, 2024

Cannabis and derivatives show promise in reducing weight and waist circumference, with nuanced effects on body fat

The study in the International Journal of Obesity reports that cannabis and its derivatives may influence weight and waist circumference, with different effects on body

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.